Feed HXPLF
HX

HEXPOL AB (publ) HXPLF OTC · Basic materials · Sweden

$9.66 +0.00% +$0.00

Summary

69 / 100 · Bulios Score

What speaks for it

  • Out of every 100 SEK of revenue, 9.3 SEK is left as net profit.
  • The share price is below the Bulios Fair Price.

What to watch

  • It cut its dividend by 20% last year.
  • Revenue fell by 4.7% a year over the last 3 years.
  • It missed profit estimates 6 times in the last 8 quarters.

Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more

Score in detail

Price

Is it expensive?

Looks cheap
Bulios Fair Price
Undervalued Price today $9.66

By our assumptions the business is worth more than its shares cost today.

P/E today 18.1 12% higher
5-year average P/E 16.1
P/E today 18.1
Chemicals - Specialty industry median

Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?

Today you pay 18.1 SEK for 1 SEK of yearly profit. Over the last five years it was 16.1 SEK on average.

Valuation in detail

Is it growing?

It is shrinking

Revenue (SEK)

Diluted EPS (SEK)

  • Analyst estimate

Revenue grew by 7.5% a year over 5 years. Over the last 3 years it fell by 4.7% a year. For the next fiscal year analysts expect revenue to grow by 6.2%. Earnings per share fell by 7.9% a year over the last 3 years.

Growth in detail

Does it make money?

Very well

Where 100 SEK of revenue goes

Net profit, industry median (Chemicals - Specialty) 6.0 SEK

Out of every 100 SEK of revenue, 9.3 SEK is left as net profit.

Profitability in detail

Is it financially healthy?

Yes

Repaying all its debt would take 2.6 years of free cash flow. Its debt is larger than its cash.

Financial health in detail

Does it pay a dividend?

High, stretched
Yield
4.71%
Paid out of profit
85%

You receive $0.45 per share a year. The payout takes a large part of its profit or free cash flow.

Dividends in detail

What do analysts expect?

No coverage

No analyst covers this stock.

Analysts in detail

What does it earn on?

By product

The company reports no revenue by product.

By region

The company reports no revenue by region.

Segments in detail

We use essential cookies to run the website and optional analytics cookies to measure usage.

Privacy policy